AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 7, 2024

A drug used to treat diabetes slowed the progression of motor issues associated with Parkinson’s disease, a study published in the New England Journal of Medicine said Wednesday. Parkinson’s is a devastating nervous system disorder affecting 10 million people worldwide, with no current cure.

Drugs 180

Drugs Medicine Clinical Trials Clinical Trials 180

Fierce Pharma

APRIL 7, 2024

Last year closed with a flurry of big-money biopharma deals. Of the industry’s top 10 acquisitions, six came in the fourth quarter. | Market research by McKinsey found that smaller, strategic M&A deals provide greater shareholder returns than multibillion-dollar acquisitions. Analysts from McKinsey and Project Farma explain why and offer advice on how to optimize deals.

Marketing 94

Marketing Research 94

JAMA Internal Medicine

APRIL 7, 2024

This randomized clinical trial seeks to determine whether d-mannose taken for 6 months reduces the proportion of women with recurrent urinary tract infections experiencing a medically attended urinary tract infection.

Clinical Trials 99

Clinical Trials Clinical Trials Trials 99

Drug Patent Watch

APRIL 7, 2024

Annual Drug Patent Expirations for RELISTOR Relistor is a drug marketed by Salix Pharms and Salix and is included in two NDAs. It is available from one supplier.

Drugs 98

Drugs Marketing 98

Advertisement

Clinical Supply

BioSpace

APRIL 7, 2024

2024 began with several biopharma players posting positive Phase III data that could mean new market share for the companies and longer survival times and quality of life for patients.

Trials 91

Trials Marketing 91

pharmaphorum

APRIL 7, 2024

FDA approves earlier use of J&J's BCMA CAR-T therapy Carvykti and BMS' rival Abecma for earlier use in multiple myeloma

FDA Approval 77

FDA Approval 77

Drug Patent Watch

APRIL 7, 2024

Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. It is available from one supplier.

Drugs 52

Drugs Marketing 52

BioSpace

APRIL 7, 2024

With second-generation antibody-drug conjugates, Eli Lilly, Daiichi Sankyo and others look to reduce toxicity and improve the magnitude and duration of response.

Antibody 88

Antibody Drugs 88

Drug Patent Watch

APRIL 7, 2024

This chart shows the pharmaceutical companies with the most patents in Japan.

Drugs 52

Drugs 52

BioSpace

APRIL 7, 2024

Helix Biostructures offers a full gene-to-structure suite of cryo-EM services that focuses on both quality and fast turnaround/throughput.

Gene 96

Gene 96

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials